• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 5. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Study of 3-Hydroxy-6-methyl-2-pyridinecarboxylic acid methyl ester (CAS: 61548-52-5)

The compound 3-Hydroxy-6-methyl-2-pyridinecarboxylic acid methyl ester (CAS: 61548-52-5) has garnered significant attention in recent years due to its potential applications in pharmaceutical and chemical research. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications. The information presented is based on a comprehensive review of recent academic literature, industry reports, and technical documents.

Recent studies have highlighted the role of 3-Hydroxy-6-methyl-2-pyridinecarboxylic acid methyl ester as a key intermediate in the synthesis of more complex molecules with potential pharmacological properties. Its structural features, including the pyridine ring and ester functionality, make it a versatile building block for drug discovery. Researchers have explored its use in the development of novel anti-inflammatory and antimicrobial agents, leveraging its unique chemical properties.

One of the most notable advancements in this area is the optimization of synthetic routes for 3-Hydroxy-6-methyl-2-pyridinecarboxylic acid methyl ester. A 2023 study published in the Journal of Medicinal Chemistry demonstrated an improved catalytic method for its synthesis, achieving higher yields and purity. This development is expected to facilitate its broader application in medicinal chemistry and reduce production costs.

In addition to its synthetic utility, recent investigations have explored the biological activity of 3-Hydroxy-6-methyl-2-pyridinecarboxylic acid methyl ester. Preliminary in vitro studies suggest that it exhibits moderate inhibitory effects on certain enzymes involved in inflammatory pathways. These findings have sparked interest in its potential as a lead compound for the development of new anti-inflammatory drugs, though further in vivo studies are needed to validate these effects.

The compound's stability and solubility profile have also been subjects of recent research. A 2024 study in the European Journal of Pharmaceutical Sciences investigated its physicochemical properties, providing valuable data for formulation scientists. The results indicated that 3-Hydroxy-6-methyl-2-pyridinecarboxylic acid methyl ester exhibits favorable solubility in common organic solvents, which is advantageous for its use in drug formulation.

Looking ahead, researchers are focusing on the derivatization of 3-Hydroxy-6-methyl-2-pyridinecarboxylic acid methyl ester to enhance its biological activity and pharmacokinetic properties. Several novel derivatives have been synthesized and are currently undergoing preclinical evaluation. These efforts are expected to yield new insights into its therapeutic potential and expand its applications in drug development.

In conclusion, 3-Hydroxy-6-methyl-2-pyridinecarboxylic acid methyl ester (CAS: 61548-52-5) continues to be a compound of significant interest in chemical and pharmaceutical research. Recent advancements in its synthesis, biological evaluation, and formulation have laid the groundwork for its potential use in developing new therapeutic agents. Future studies will likely focus on optimizing its derivatives and exploring their mechanisms of action in greater detail.

• 808118-20-9(3-Isoquinolinecarboxylicacid, 4-hydroxy-1-methyl-, methyl ester)
• 62733-99-7(methyl 3-hydroxypyridine-2-carboxylate)
• 1632-19-5(Dimethyl 3,4-dihydroxy-1H-pyrrole-2,5-dicarboxylate)
• 24059-83-4(Methyl 3-methoxypyridine-2-carboxylate)
• 164398-85-0(Ethyl 3-methoxypicolinate)
• 65171-89-3(3-hydroxy-1H-Pyrrole-2-carboxylic acid ethyl ester)
• 62734-00-3(2-Pyridinecarboxylic acid, 3-methoxy-, methyl ester, hydrochloride)
• 65515-24-4(2-Pyridinecarboxylicacid, 3-methoxy-6-methyl-, methyl ester)
• 73406-50-5(Ethyl 3-hydroxypicolinate)
• 79068-31-8(Methyl 3-hydroxy-1H-pyrrole-2-carboxylate)